Suzhou Basecare Medical Corp. Ltd. Class H (HK:2170) has released an update.
Suzhou Basecare Medical Corporation Limited has voluntarily announced a significant revenue increase for the first half of 2024, primarily due to the acquisition of BMX Holdco Pte. Ltd. and strong sales growth both internationally and in the Chinese market, underpinned by supportive local policies for assisted reproductive projects. The preliminary unaudited financials indicate robust performance, particularly in equipment and product sales, with further growth anticipated. Investors are reminded to approach the company’s interim results cautiously, as the final report, subject to audit adjustments, will be published in August 2024.
For further insights into HK:2170 stock, check out TipRanks’ Stock Analysis page.
